Growth Metrics

Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026)

Scholar Rock Holding's quarterly Total Current Liabilities came in at $59.6 million in Q1 2026, up 58.73% year-on-year from $37.6 million in Q1 2025, and up 7.62% quarter-over-quarter from $55.4 million in Q4 2025.

Scholar Rock Holding has reported Total Current Liabilities for 10 years, with the latest figure at $59.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 58.73% year-over-year to $59.6 million; the trailing twelve-month figure through Mar 2026 stood at $59.6 million (up 58.73% YoY), and the FY2025 full-year result was $55.4 million, up 18.07% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $59.6 million, up from $55.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $62.0 million in Q3 2025, with the low at $24.3 million in Q2 2023.
  • Average Total Current Liabilities over 5 years is $39.7 million, with a median of $37.5 million recorded in 2024.
  • Year-over-year, Total Current Liabilities slumped 52.29% in 2022 and soared 58.73% in 2026.
  • Tracing SRRK's Total Current Liabilities over 5 years: stood at $36.4 million in 2022, then fell by 10.03% to $32.7 million in 2023, then jumped by 43.36% to $46.9 million in 2024, then climbed by 18.07% to $55.4 million in 2025, then climbed by 7.62% to $59.6 million in 2026.
  • The last three Total Current Liabilities figures came in at $59.6 million (Q1 2026), $55.4 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 59.64 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 59.64 Mn
Dec 31, 2025 55.42 Mn
Sep 30, 2025 61.97 Mn
Jun 30, 2025 50.44 Mn
Mar 31, 2025 37.57 Mn
Dec 31, 2024 46.94 Mn
Sep 30, 2024 39.37 Mn
Jun 30, 2024 32.99 Mn
Mar 31, 2024 37.51 Mn
Dec 31, 2023 32.74 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 24.27 Mn
Mar 31, 2023 26.21 Mn
Dec 31, 2022 36.39 Mn
Sep 30, 2022 33.74 Mn
Jun 30, 2022 40.16 Mn
Mar 31, 2022 33.37 Mn
Dec 31, 2021 64.30 Mn
Sep 30, 2021 64.60 Mn
Jun 30, 2021 67.02 Mn
Mar 31, 2021 69.96 Mn
Dec 31, 2020 42.56 Mn
Sep 30, 2020 32.87 Mn
Jun 30, 2020 32.57 Mn
Mar 31, 2020 27.10 Mn
Dec 31, 2019 32.81 Mn
Sep 30, 2019 32.52 Mn
Jun 30, 2019 32.05 Mn
Mar 31, 2019 34.08 Mn
Dec 31, 2018 31.12 Mn
Sep 30, 2018 5.76 Mn
Jun 30, 2018 6.69 Mn
Dec 31, 2017 5.02 Mn